Mode of action
Mode of action
Tenecteplase is a recombinant fibrin-specific plasminogen activator that is derived from native tissue plasminogen activator (t-PA) through modifications at three sites of the protein structure. It binds to the fibrin component of the thrombus (blood clot) and selectively converts thrombus-bound plasminogen to plasmin. Plasmin degrades the fibrin mesh thereby dissolving the clot.
Compared to native t-PA, Metalyse® has a higher fibrin specificity and greater resistance to inactivation by its endogenous inhibitor (PAI-1).1
![Acute Ischaemic Stroke (AIS) and tenecteplase Acute Ischaemic Stroke (AIS) and tenecteplase](/strokeforum/sites/default/files/2024-05/Acute-Ischaemic-Stroke-and-tenecteplase-thumbnail.jpg)
Acute Ischaemic Stroke (AIS) and tenecteplase
A short video introducing AIS, hemostasis, and tenecteplase - its mode of action and use
Reference
-
1.
European Summary of Product Characteristics. Boehringer Ingelheim International GmbH. January 2024. Metalyse | European Medicines Agency (europa.eu)